| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0081 | 0.9 |